Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-20

FDA Approved: VOCABRIA — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for Vocabria (cabotegravir sodium) submitted by ViiV Healthcare Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VOCABRIA (cabotegravir sodium)

Snippet

SUPPL AP for VOCABRIA (CABOTEGRAVIR SODIUM)